ATOSSA THERAPEUTICS, INC.: accounts_payable
| Value | {"amount": 513045, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2014-12-31) |
| Status | current |
| Entity | ATOSSA THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:48:01.895087+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/bf73cbf0-5ded-46fd-8ce6-14e11142b433
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-16-091380 · Open the official SEC filing →Retrieved: 2026-08-19T14:48:01.895087+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001488039/accounts-payable/2014-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/bf73cbf0-5ded-46fd-8ce6-14e11142b433
History
- supersedes {"amount": 594357, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} (evidence 0001144204-15-019344)